home / stock / mrna / mrna articles

MRNA Articles, Moderna Inc. - From 06/18/24

Stock Information
Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com
Menu
MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment | Benzinga

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its ...
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report | Benzinga

Microsoft Corp (NASDAQ:MSFT) backed OpenAI, in partnership with startup Color Health, has unveiled a new initiative to harness artificial intellige...

Moderna Submits Updated COVID-19 Jab to FDA for Review | Benzinga

Moderna, Inc. (NASDAQ: MRNA) announced that it has submitted an application to the FDA seeking approval of its Spikevax 2024-2025 formula, tar...

Nike, Merck, General Motors, And More: CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Liz Young of SoFi named The Energy Select Sector SPDR Fund (NYSE:XLE) as her final trade...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season | Benzinga

On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which target...

First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map | Benzinga

Vaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting people around the globe. On Thursday, a 59-yea...

FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program | Benzinga

Thursday, the FDA selected Moderna Inc’s (NASDAQ:MRNA) mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (STA...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA | Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Moderna, Inc. ("Moderna" or the "C...

What's Going On With Novavax Stock? | Benzinga

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at w...

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon | Benzinga

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage tri...
Previous 10 Next 10